305 related articles for article (PubMed ID: 15190522)
1. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients.
Ferri C; Sebastiani M; Giuggioli D; Cazzato M; Longombardo G; Antonelli A; Puccini R; Michelassi C; Zignego AL
Semin Arthritis Rheum; 2004 Jun; 33(6):355-74. PubMed ID: 15190522
[TBL] [Abstract][Full Text] [Related]
2. Mixed cryoglobulinemia.
Ferri C
Orphanet J Rare Dis; 2008 Sep; 3():25. PubMed ID: 18796155
[TBL] [Abstract][Full Text] [Related]
3. Cryoglobulinemia.
Morra E
Hematology Am Soc Hematol Educ Program; 2005; ():368-72. PubMed ID: 16304405
[TBL] [Abstract][Full Text] [Related]
4. [Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia (review)].
Ghinoi A; Mascia MT; Puccini R; Ferri C
G Ital Nefrol; 2004; 21(3):225-37. PubMed ID: 15285001
[TBL] [Abstract][Full Text] [Related]
5. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature.
Giuggioli D; Manfredi A; Colaci M; Manzini CU; Antonelli A; Ferri C
Autoimmun Rev; 2013 Sep; 12(11):1058-63. PubMed ID: 23806565
[TBL] [Abstract][Full Text] [Related]
6. Anti-endothelial cell auto-antibodies in hepatitis C virus mixed cryoglobulinemia.
Cacoub P; Ghillani P; Revelen R; Thibault V; Calvez V; Charlotte F; Musset L; Youinou P; Piette JC
J Hepatol; 1999 Oct; 31(4):598-603. PubMed ID: 10551381
[TBL] [Abstract][Full Text] [Related]
7. Mixed cryoglobulinemia and hepatitis C virus.
Cacoub P; Fabiani FL; Musset L; Perrin M; Frangeul L; Leger JM; Huraux JM; Piette JC; Godeau P
Am J Med; 1994 Feb; 96(2):124-32. PubMed ID: 7509124
[TBL] [Abstract][Full Text] [Related]
8. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia.
Cacoub P; Renou C; Kerr G; Hüe S; Rosenthal E; Cohen P; Kaplanski G; Charlotte F; Thibault V; Ghillani P; Piette JC; Caillat-Zucman S
Arthritis Rheum; 2001 Sep; 44(9):2118-24. PubMed ID: 11592376
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Ferrari SM; Ghiri E; Marchi S; Sebastiani M; Fallahi P
J Rheumatol; 2010 Jan; 37(1):91-7. PubMed ID: 19918044
[TBL] [Abstract][Full Text] [Related]
10. Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy.
Landau DA; Scerra S; Sene D; Resche-Rigon M; Saadoun D; Cacoub P
J Rheumatol; 2010 Mar; 37(3):615-21. PubMed ID: 20110523
[TBL] [Abstract][Full Text] [Related]
11. Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection.
Matignon M; Cacoub P; Colombat M; Saadoun D; Brocheriou I; Mougenot B; Roudot-Thoraval F; Vanhille P; Moranne O; Hachulla E; Hatron PY; Fermand JP; Fakhouri F; Ronco P; Plaisier E; Grimbert P
Medicine (Baltimore); 2009 Nov; 88(6):341-348. PubMed ID: 19910748
[TBL] [Abstract][Full Text] [Related]
12. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia.
Saadoun D; Sellam J; Ghillani-Dalbin P; Crecel R; Piette JC; Cacoub P
Arch Intern Med; 2006 Oct; 166(19):2101-8. PubMed ID: 17060540
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment.
Schott P; Hartmann H; Ramadori G
Histol Histopathol; 2001 Oct; 16(4):1275-85. PubMed ID: 11642746
[TBL] [Abstract][Full Text] [Related]
14. Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia.
Antonelli A; Ferri C; Fallahi P; Giuggioli D; Nesti C; Longombardo G; Fadda P; Pampana A; Maccheroni M; Ferrannini E
QJM; 2004 Aug; 97(8):499-506. PubMed ID: 15256607
[TBL] [Abstract][Full Text] [Related]
15. Impact of mixed cryoglobulinemia on patients with spontaneous hepatitis C virus clearance: A 13-year prospective cohort study.
Lee KC; Cheng YT; Lin CY; Kuo CJ; Chien RN; Yeh CT; Chang ML
Eur J Clin Invest; 2020 Jan; 50(1):e13189. PubMed ID: 31782138
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role.
Zignego AL; Ferri C; Giannini C; La Civita L; Careccia G; Longombardo G; Bellesi G; Caracciolo F; Thiers V; Gentilini P
Arch Virol; 1997; 142(3):545-55. PubMed ID: 9349300
[TBL] [Abstract][Full Text] [Related]
17. Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus.
Sene D; Ghillani-Dalbin P; Thibault V; Guis L; Musset L; Duhaut P; Poynard T; Piette JC; Cacoub P
J Rheumatol; 2004 Nov; 31(11):2199-206. PubMed ID: 15517633
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous vasculitis and rheumatoid factor positivity as presenting signs of hepatitis C virus-induced mixed cryoglobulinemia.
Karlsberg PL; Lee WM; Casey DL; Cockerell CJ; Cruz PD
Arch Dermatol; 1995 Oct; 131(10):1119-23. PubMed ID: 7574826
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests.
Casato M; Saadoun D; Marchetti A; Limal N; Picq C; Pantano P; Galanaud D; Cianci R; Duhaut P; Piette JC; Fiorilli M; Cacoub P
J Rheumatol; 2005 Mar; 32(3):484-8. PubMed ID: 15742440
[TBL] [Abstract][Full Text] [Related]
20. High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia.
Antonelli A; Ferri C; Ferrari SM; Ghiri E; Marchi S; Colaci M; Bruschi F; Fallahi P
Clin Rheumatol; 2009 Oct; 28(10):1179-85. PubMed ID: 19543846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
